Clinical Trials Logo

Breast Fibroadenoma clinical trials

View clinical trials related to Breast Fibroadenoma.

Filter by:

NCT ID: NCT02488655 Completed - Breast Fibroadenoma Clinical Trials

Treatment of Breast Fibroadenoma With FastScan HIFU

Start date: June 2015
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of the HIFU for the treatment of breast fibroadenoma with the FastScan version using assessment of patient experience and adverse event reporting.

NCT ID: NCT02139683 Completed - Breast Fibroadenoma Clinical Trials

Feasibility Study Assessing the Treatment of Fibroadenomata With a Circumferential Sonication Treatment With HIFU

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the treatment of fibroadenomata with a circumferential sonification treatment with HIFU..

NCT ID: NCT02078011 Completed - Breast Fibroadenoma Clinical Trials

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound

HIFU-FA-001
Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to test an investigational device called the Echopulse for treatment of breast fibroadenomas in women. Fibroadenomas are benign (noncancerous) breast tumors that are made of glandular and fibrous breast tissue. These lumps can occur alone, in groups, or as a complex of lumps together. Sometimes women feel these in the breast when doing regular self breast exams, or they may be found during a routine mammogram. Some are small (less than an inch in size), and others are quite large (the size of a lemon or larger). This is a study about the Echopulse device, a computer driven system which uses ultrasound to guide a high intensity focused ultrasound beam to a targeted area (the fibroadenoma in the breast). The high intensity focused ultrasound (HIFU) heats the targeted site which causes the cells to die and allows the possibility to treat the fibroadenoma without the need for surgery.

NCT ID: NCT02011919 Completed - Breast Fibroadenoma Clinical Trials

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

HIFU
Start date: December 2013
Phase: N/A
Study type: Interventional

This is a monocenter, open-label, uncontrolled study in accordance with §23b MPG to evaluate the efficacy of the HIFU-treatment of fibroadenoma using the TH-One device Objectives Primary objective: To evaluate the efficacy of HIFU in the treatment of the breast fibroadenoma using the TH-One device Secondary objective: To evaluate the tolerability of the HIFU using the TH-One device

NCT ID: NCT01422629 Completed - Breast Fibroadenoma Clinical Trials

High Intensity Focused Ultrasound (HIFU) to Treat Breast Fibroadenoma

Start date: October 2011
Phase: N/A
Study type: Interventional

This study is a multicentre, open, uncontrolled trial for the observation of histological changes in breast fibroadenoma following high intensity focused ultrasound (HIFU). This study will be conducted in France in 20 patients with breast fibroadenoma with indication for a surgical resection. The patient will receive an HIFU treatment and 6 months after treatment, the need of the surgery is evaluated.

NCT ID: NCT01331954 Active, not recruiting - Breast Fibroadenoma Clinical Trials

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

Start date: March 2011
Phase: N/A
Study type: Interventional

Demonstrate the efficacy of High Intensity Focused Ultrasound in the treatment of the breast fibroadenoma.

NCT ID: NCT00147108 Terminated - Breast Fibroadenoma Clinical Trials

MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas

Start date: January 2003
Phase: Phase 3
Study type: Interventional

The primary objective of this pivotal study is to evaluate the safety and efficacy of FUS treatment of breast fibroadenomas. Our hypothesis is that FUS lesion ablation of a fibroadenoma will have the following results: a. lead to a decrease in lesion cross-sectional area of > 50% on palpation, and >65% in lesion volume as measured by MRI (both calculations assume an elliptical shape of the lesion in all 3 dimensions). b. this decrease in size, along with the softening of the treated volume will result in satisfactory clinical results in greater than 50 % of the patients.